
Investornewsbreaks Silo Pharma Inc. (NASDAQ: SILO) Files Patent Application For Alzheimer's Drug SPC-14
(MENAFN- Investor Brand Network) Silo Pharma (NASDAQ: SILO) announced the filing of a patent application with the U.S. Patent and Trademark Office for SPC-14, a novel intranasal compound exclusively licensed from Columbia University targeting cognitive and …